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a  b  s  t  r  a  c  t
The  patients’  rights  and  cross-border  health  care  directive  was  implemented  in  Malta  in
2013. Malta’s  transposition  of the  directive  used  the  discretionary  elements  allowable  to
retain  national  control  on  cross-border  care to the  fullest  extent.  This  paper  seeks  to  ana-
lyse the underlying  dynamics  of this  directive  on  the Maltese  health  care  system  through
the  lens  of  key  health  system  stakeholders.  Thirty-three  interviews  were  conducted.  Quali-
tative content  analysis  of  the  interviews  reveals  six key  themes:  fear  from  the potential
impact  of  increased  patient  mobility,  strategies  employed  for damage  control,  oppor-
tunities  exploited  for  health  system  reform,  moderate  enhancement  of patients’  rights,
negligible  additional  patient  mobility  and  unforeseen  health  system  reforms.  The  ﬁndings
indicate  that  local  stakeholders  expected  the  directive  to have  signiﬁcant  negative  effects
and  adopted  measures  to  minimise  these  effects.  In practice  the directive  has  not  affected
patient mobility  in  Malta  in  the  ﬁrst months  following  its  implementation.  Government
appears  to  have  instrumentalised  the  implementation  of the  directive  to implement  certain
reforms including  legislation  on  patients’  rights,  a  health  beneﬁts  package  and  compulsory
indemnity  insurance.  Whilst  the  Maltese  geo-demographic  situation  precludes  automatic
generalisation  of the conclusions  from  this  case  study  to  other  Member  States,  the  ﬁndings
serve  to advance  our  understanding  of the  mechanisms  through  which  European  legislation
on  health  services  is  inﬂuencing  health  systems,  particularly  in small  EU Member  States.
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Introduction
The patients’ rights and cross-border health care direc-
tive [1] is a landmark [2] in European health care politics,
yet its potential to lead to a widespread impact upon Mem-
ber States’ (MS) health care systems is open to debate [3–6].
The directive deals with people seeking to go abroad for
health care on their own  initiative as distinct from care that
becomes necessary during a temporary visit, care sought
by retirees in other countries, care sought across borders
in border regions or people sent abroad for care organised
by their home systems [7].
is is an open access article under the CC BY-NC-ND license
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Early non-exhaustive reviews of the implementation
of the cross-border directive reveal mixed results [8]. MS
with systems that ﬁt less well with EU legislation may
be expected to experience larger adaptations [9,10]. MS
with national health service type systems would have to
undergo more signiﬁcant changes in order to align their
health care systems with the requirements of the cross-
border care directive [11–13]. The impact assessment of
the Commission’s proposal for a directive had highlighted
the fact that small MS  are [8] likely to face a greater ﬁnancial
impact as a result of cross-border care [14].
In Malta cross-border patient care is mainly based on
structured cooperation agreements with the United King-
dom [15], and speciﬁc Italian regions [16]. In 2013, 423
patients received organised care overseas, approximately
0.1% of the population [17]. Studies of patient experiences
in the national overseas highly specialised care programme
have overall revealed a high level of satisfaction [18,19]
and the need for an additional type of patient mobility may
therefore not feature highly in the Maltese population.
The paper seeks to illustrate how Europeanisation of
health care is taking place in a small island EU Member
State using the example of the patients’ rights and cross
border health care directive. Malta’s smallness, its ‘national
health service’ type system and long-standing organised
cross-border care provides an interesting case study on
how the cross-border directive has impacted on its health
system. Such case studies are useful for studying European
policy processes [20,21] and are applicable in the ﬁeld of
Europeanisation [22]. A brief description of the Maltese
health system situates the empirical ﬁndings in the appro-
priate context (see Box 1).
Box 1: Key facts about the Maltese health care
system.
Malta acceded to the EU in 2004. It is the smallest
MS  in the EU with a population of 417,432 and a total
land area of 315 km2. The publicly funded health care
system is the key provider of health services. The
private sector complements provision in particular in
the area of primary care and ambulatory specialist
care. The Ministry is responsible for setting policy and
standards, for regulation of public and private health
services as well as for funding and direct organisation
and delivery of health care. The public health sys-
tem is funded by general tax revenues. Total health
expenditure was 8.7% of Malta’s GDP in 2012 of which
public spending was only 5.6% of GDP. Sustainability
of the health system has become identiﬁed as a key
challenge and the Maltese health system has come
under the scrutiny of the European Semester process.
In 2013 and 2014 Malta has received Country Speciﬁc
Recommendations (CSRs) calling for a comprehensive
reform of the health system to improve the efﬁciency
and sustainable use of available resources.
Source – Health Systems in Transition Vol. 16
No. 1 2014; Malta Health System Review available
at https://www.ecoi.net/ﬁle upload/1930 1421314107
hit-malta.pdf accessed on 08/03/2015.Prior to 2013, Government had not implemented the
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was  found to be in breach of Law by the domestic judicial
system [23]. The Health Act [24] and the accompanying reg-
ulations on cross-border health care came into force on the
25 October 2013 [25]. The directive presumes the existence
of a clear beneﬁts entitlement package as well as a system
to determine exactly who  is entitled to access cross-border
care. The Health Act provides for a formal and transparent
mechanism for the establishment of the beneﬁts package
as well as a publicly accessible register of treatments and
services offered by the public health system. This can be
considered as a response to a national Court Case regarding
Government’s failure to approve public funding of overseas
treatment for a joint kidney-pancreas transplant which
Government lost case due to the lack of a publicly avail-
able health care beneﬁts package [23]. The Health Act also
introduces an explicit legal reference to patients’ rights for
the ﬁrst time in Malta.
The detailed implementation of the directive occurs
through the regulations on cross-border health care [25].
These regulations primarily establish the role and respon-
sibility of the National Contact Point. Domestic private
providers are categorically excluded from the scope of the
regulations as is the reimbursement of travel and ancil-
lary costs. Emphasis on the obligation to fulﬁl all clinical
and administrative formalities that are used to establish
access to services within the Maltese health care system is
evident, such as the use of clinical protocols and the need
to be referred through the general practitioner gatekeep-
ing system. The regulations also stipulate the ability of the
competent authority to limit access to cross-border care
in circumstances where the continued provision of high
quality domestic care without waste of resources could be
threatened. All the provisions in the directive that are listed
as possible justiﬁcations for a prior authorisation system
appear in the Maltese cross-border regulations.
The obligation for all health professionals to have appro-
priate indemnity insurance appears for the ﬁrst time in
Maltese legislation in the Indemnity Insurance Regulations
[26]. The implementation of obligatory indemnity insur-
ance was considered to be an important and sensitive
issue [27,28]. Previously, health care professionals were not
required to have any form of indemnity insurance in the
private sector and therefore this new provision introduced
an additional cost for professionals which could be passed
on to the patient. In a health care system where 35% of total
expenditure takes place primarily through out of pocket
payment in the private sector [29], upward pressure on
tariffs particularly in primary care may  have an important
impact. Whilst Government employees were implicitly de
facto covered, there was no ofﬁcial legal reference to such
cover and the lack of legal certainty was an issue that had
been previous raised by trade unions in the health sector.
Methods
The theoretical framework adopted for this study is that
of “Europeanisation” and the classic deﬁnition by Radaelli
[30] of Europeanisation as ‘a series of top-down and bottom-
up processes affecting both formal and informal rules as well
as procedures, policy paradigms, styles and shared beliefs and
norms’ is applied.
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Table  1
List of interviewees by primary role.
Role Number of interviewees
Academic 3
Public health civil servant 13
Politician 5
Clinician 3
European Affairs civil servant 4
Industry 1
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of expertise and loss of pathology” (P5 health civil servant)Civil Society 4
Total 33
Content analysis of verbatim interview transcripts,
btained from thirty-three face-to-face interviews in July
nd August 2014, was undertaken. A maximal purposeful
ampling approach was adopted [21] in order to obtain
he viewpoint of diverse health system stakeholders. The
ample consisted of senior leaders from public health,
ivil servants from the Ministries of Health and European
ffairs, politicians, senior clinicians and leaders in civil soci-
ty. The key inclusion criterion was that participants were
ither in a leadership position in the health care system
r European affairs practitioners for several years. Partici-
ants were selected on the basis of the role they currently
r previously held e.g. Minister, Director, Secretary of Trade
nion. Table 1 provides a description of the interviewees’
rofessional background and primary role description. No
ender and age disaggregation is given to reduce the risk of
dentiﬁcation of the respondents given the small numbers
f stakeholders who occupy key positions in the Maltese
ealth care system.
Thirty-ﬁve participants were approached through an e-
ail by the principal investigator. Two persons declined
o participate stating that they did not feel they had the
equired expertise. Written informed consent for audio
ecording was obtained prior to the interviews.
The questions were open-ended and asked about the
nterviewee’s beliefs, attitudes and experience regarding
heir experience of the impact of Malta’s EU membership
pon the health care system. Further probing was used to
ain additional insights on speciﬁc topics that respondents
entioned during the interview, including the implemen-
ation of the cross-border care directive. The interviews
ere audio recorded and transcribed in full.
Each interview was coded in parallel by two persons
ollowing an inductive approach supported through QSR
vivo 10. Codes were compared and discussed among the
embers of the research team while allowance was made
or the continued creation of new codes. The stakeholders’
erceptions regarding the patients’ rights and cross-border
irective and its impact on the domestic health system
ere explored through qualitative content analysis. Thick
escriptions of the emerging themes including “cross-
order” and “patients’ rights” were developed. Key word
earches in the transcripts for “cross-border” and “patients’
ights” ensured that all relevant statements were identi-
ed. Discussion between the research team was carried out
ntil consensus on the themes and their inter-relationships
as reached. Permission to carry out this study was  sought
nd obtained from the University Research Ethics Commit-
ee (UREC) at the University of Malta.olicy 119 (2015) 1285–1292 1287
Results
Seventy-nine “cross-border” and 103 “patients’ rights”
references were identiﬁed in the transcripts. Fig. 1 depicts
the results of the study showing how the mechanism of
Europeanisation in the form of implementing a directive
led to three main impacts according to the interview-
ees: moderate enhancement of patients’ rights, negligible
additional patient mobility and unforeseen reform in the
domestic health care system. Furthermore, it was possible
to identify three main streams of perceptions of emotions
and behaviours: fear of the potential impact of increased
patient mobility, strategies employed for damage control
and the exploitation of opportunities for domestic health
system reform. These themes are presented in two main
groups as the reported perceptions and behaviour triggered
by the directive and the actual early impact of the directive
as perceived by the interviewees.
Perceptions and behaviour triggered by the directive
Fear from the potential impact of increased patient
mobility
All stakeholders groups, with the exception of civil soci-
ety representatives, expressed fears about the ﬁnancial
implications associated with the possibility of the directive
leading many patients to seek cross-border care. Lengthy
waiting lists for cataracts and orthopaedic surgery were the
main factors cited for the expected patient exodus.
“The fear was that with our waiting lists – especially in
things like cataracts and orthopaedic surgery, we might
be facing an exodus of patients trying to make use of the
Cross-Border Healthcare.” (P17 health civil servant)
Other factors mentioned included the perceived better
quality of care in larger Member States and the propensity
of Maltese patients to seek care overseas. However several
respondents readily equally acknowledged that this much-
feared threat had actually not yet materialised and referred
to it as a future challenge as exempliﬁed below.
“I think we felt that this (the cross-border directive) could
have been very challenging to us because we thought that
it might lead to an increase in expenditure which would
be difﬁcult to cover given that the Maltese are very keen
on going abroad, more than other EU citizens. This has not
yet materialised but it was  looked at with trepidation” (P4
clinician)
Fear regarding the outward mobility of health care pro-
fessionals and the potential loss of patients manifesting
speciﬁc diseases since the decrease in patient volume could
have a subsequent negative impact on clinical expertise,
was an important theme mentioned in the small country
context.
“I think the big risk, in my opinion, is the outward mobilityOn the other hand the potential inﬂux of patients into
the domestic health system was  mentioned as a key con-
cern by a minority of respondents.
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 borderFig. 1. The impact of the patients’ rights and cross
“From a service provision side perspective, there is a pos-
sibility of seeing a surge of the patients who may use our
healthcare system because it is reputed to be quite a good
healthcare system.” (P24 health civil servant)
Strategies employed for damage control
Civil servants dominantly contributed to the theme
of “damage control” which appears to have prevailed as
an established approach from the early days of lobbying
efforts. Reportedly, attempts were made to modify the
Commission’s proposal for the directive, by for example,
ensuring that prior authorisation, not initially included in
the proposal, was eventually inserted in the text.
“The way in which the cross border directive itself was
starting to move, for example, ﬁrst prior authorisation was
not included and then eventually it did get into the text.”
(P13 health civil servant)
This “damage control” behavioural approach to coun-
teract the expected patient outﬂows is believed to have
prevailed during the transposition and implementation
process. Civil servants attribute the application of such
restrictions to the observation that no sudden patient out-
ﬂows were actually experienced.
“I think the way it was transposed, the way it was applied
locally – ensured that till now the expected exodus didn’t
happen. . ..we have not been able to exploit cross-border
health care but we have been more focussed on the damage
control agenda at this point.” (P17 MoH  civil servant)
Several civil society representatives report that Gov-
ernment carried out a minimalist, correct implementation
without actively encouraging patients to make use of their
rights as exempliﬁed by the two excerpts below.“The Government is trying to act according to the policy
but actually not enforcing it, not encouraging them to seek
cross border care and the public is not that fully aware to
go search for these things” (P16 civil society) care directive on the Maltese health care system.
“Hopefully we  will soon have a full transposition in
practice, because in theory, we have it, but in practice we
have to see” (P19 politician)
Opportunities exploited for health system reform
All stakeholder groups generally perceive the directive
as a turning point because Governments came under pres-
sure from the EU to provide their citizens with good health
care.
“The Cross Border Directive has basically got us to look into
the way we provide health services.” (P21 European affairs
practitioner)
Some civil servants and clinicians viewed the directive
as an attempt by the European Commission to introduce a
minimum level or standard of health care in all MS.
“Now, in the name of having the same standards every-
where, they (the European Commission) could introduce
a minimum level or standard in all Member States.” (P7
health civil servant)
For several stakeholders the directive was perceived to
be instrumental in introducing legislation which had been
repeatedly postponed.
“I think it is the Health Bill. We  have just seen it happen. It
had been for I don’t know how long for, but it was a Par-
liament point on their agenda, which had been postponed,
but as soon as the Cross Border Healthcare Directive came
into force, the bill was implemented.” (P28 civil society
representative)
A public health civil servant also contended
that the directive served as an impetus to enact leg-
islation on the organisation and governance of the
departments within the Ministry for Health.
“The healthcare act wouldn’t have been implemented if it
were not for the cross-border directive. However not all
the reforms in the Health Act were directly related to the
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Directive. I’d say that part of the content of the Health Act,
is purely related to national matters for example, the orga-
nisational structure is not imposed by the EU. So the Health
Act was pushed because of the EU Directive deadline but
we managed to include strictly national issues” (P5 health
civil servant)
erceived impact of the implementation of the patients’
ights and cross border health directive
nforeseen health system reforms
Generally civil society representatives felt that the
ross-border directive raised awareness on the manner in
hich the EU can impact the health system.
“Civil society organisations think that the EU will never
inﬂuence the way we think and give advice because of the
famous myth that has been ampliﬁed and disseminated,
that is, EU accession will not affect our national health
system. But we know that due to the directive, policies,
legislation, even guidelines–we will be affected. Now we
have been feeling and living it especially after the imple-
mentation of the cross-border directive” (P28 civil society)
Amongst civil servants the reform of the entitlement
ystem and the introduction of a health care package are
entioned as important indirect outcomes of the direc-
ive’s implementation. Entitlement became important for
ear of having to refund someone for costly treatment over-
eas when that person was not even entitled to coverage
nder the Maltese health system.
“The entitlement issue became important because you have
to determine who is entitled in Malta, and the health care
package, where we started to determine what services we
can offer clearly to our clients was introduced.” (P5 health
civil servant)
The introduction of professional indemnity insurance
here the directive is believed to have played a determin-
ng role in ensuring compulsory indemnity insurance for
ll health care professionals was mentioned as an impor-
ant outcome by several stakeholders as captured in the
xcerpts below.
“The cross-border directive led us to the application of bet-
ter standards, like the Indemnity issue. We  wouldn’t have
introduced the indemnity issue had there not been the EU
directive for sure. . .”  (P7 health civil servant)
“We  had the success story of the professional indemnity
coverage of professionals. We  knew that it was a very small
paragraph in the cross-border healthcare directive. . .as
soon as we saw it we started working on it as an organi-
sation.” (P28 civil society)
The directive reportedly created a greater awareness of
edico-legal issues and according to a health civil servant
cted as a powerful stimulus to provoke changes in practice
uch as in the prescription and dispensing of medicines
here enforcement had been an outstanding problem.
For all stakeholder groups, the directive is considered
s a force that will place pressure on the domestic health
ervices and lead to tangible patient beneﬁts, if properlyolicy 119 (2015) 1285–1292 1289
applied, going farther than the original notion of lay-
ing down rules for patient mobility and having future
effects on the Maltese health system as stated clearly by a
politician.
“My  idea of the Cross-Border Directive is not so much
the rights that it introduces in terms of people seeking
treatment abroad but the inherent pressure on the local
authorities to give a better service to Maltese citizens in
order to prevent them arriving at the stage when they
need to use the Cross-Border Directive. I always looked at
EU legislation broadly, including the Cross-Border Direc-
tive, as a force that applies pressure on us to change (P18
politician).”
Moderate enhancement of patients’ rights
Most interviewees felt that the directive provided the
impetus for patients’ rights legislation to be enacted and
strongly doubted whether this legislation would have been
implemented without the need to comply with the EU
requirement.
“I don’t think this question of patients’ rights, for example,
would have ever materialised had it not been because we
needed to comply with EU legislation.” (P26 clinician)
A civil society representative mentioned that Maltese
patients are very passive when compared to their European
counterparts. The externally-pushed obligation for legis-
lation on patients’ rights to be adopted in a system that
was not culturally ready seems to have led to a situation
where although the legislative framework was adopted,
most stakeholders were sceptical since patients still lack
empowerment and very little has been done on issues of
compensation and redress as strongly voiced by a senior
health civil servant.
“We  are failing on patients’ rights we are not sensitive
enough to patients’ rights even though we may have them
written on paper they are not at all respected in practice.”
(P13 health civil servant)
Negligible additional patient mobility
Finally there was broad consensus around the fact that
the directive to date has not had a real impact on patient
mobility with free movement of patients still being ‘embry-
onic’ (P24 health civil servant). The lack of information and
the gap between patients’ expectations and what is pos-
sible in practice were mentioned as two  key barriers. A
health civil servant remarked that patients may  have been
given the impression that they have a right to every treat-
ment that exists in the European Union countries when in
practice there are several restrictions on what is covered
and reimbursed.
“I don’t think that people understand it very well yet. They
think that they can go abroad, get their service and come
back. In reality, there are restrictions, it is not so open” (P7
health civil servant)
Furthermore an EU affairs practitioner observed that the
EU patient mobility framework could be reformed to make
it more patient friendly.
ealth P1290 N. Azzopardi-Muscat et al. / H
An academic raised the concern that patient mobility is
for people who  have money and described it as ‘somewhat
of a dream’ (P1 academic).
The fact that patients only have a right to be reimbursed
the local cost of the intervention is considered to be a major
barrier by several stakeholders. This is well described by a
politician.
“Maltese patients are at a very big disadvantage because
they have to pay for their airfare and they only get refunded
what the operation costs in Malta. This brings inequity
between Maltese patients and patients in other European
countries”. (P25 politician)
In conclusion some interviewees, mostly civil servants,
believe that the impact will be minimal, particularly if
issues such as waiting lists are addressed.
“Personally I do not think it will be a big impact if we take
steps to sort out certain health system issues” (P13 health
civil servant)
“I think that the Maltese people are very territorial and
have a very high opinion of our healthcare services. So
only very few would opt, in my opinion, to seek treat-
ment abroad, in those cases where they can’t have it here
in Malta (P24 health civil servant)
On the other hand other stakeholders believe that the
directive will have a greater impact in future.
“I mean, it is a bit early but I think in the long run we will
start seeing the impact in different areas of health provision
(P21 EU affairs practitioner).
“I still believe that it is going to be a challenge but it will not
be a challenge just for Malta, it will be a challenge for a lot of
European countries. Pleasures yet to come...” (P3 politician)
Discussion
This study has sought to analyse how the implemen-
tation of the cross-border directive has impacted upon
the Maltese health care system. It has demonstrated how
Europeanisation is occurring in health systems through a
two-way relationship between EU level instruments and
domestic actors embedded in their culture and context.
Several key lessons emerge from this case study. Firstly,
a high level of anticipated negative impact led to a restric-
tive approach which was taken to limit patient mobility.
This in turn resulted in minimal utilisation of the rights
bestowed by the directive with regards to cross-border
care. The extensive use of prior authorisation and the deci-
sion to exclude private domestic providers from the local
legislation are examples of such controls. Secondly, the
directive was viewed as having potentially positive impli-
cations as a welcome external force for change on issues
such as patients’ rights, standards of care, transparency and
governance within the health system. Finally, in line with
Legido-Quigley et al. [31], it was shown how contextual
and cultural issues may  greatly inﬂuence the legacy that
speciﬁc directives have.olicy 119 (2015) 1285–1292
Despite the fact that the Maltese reported the highest
rate of willingness to seek cross-border healthcare services
at 78% in 2015 [32], this ﬁgure remained relatively stable
since 2007, (82%) [33] with the early impact of the patients’
rights and cross-border healthcare directive on the Maltese
health system appearing to be limited in terms of patient
mobility. The relatively high degree of satisfaction with the
local health care system (94%) [34] and the existence of
well-established alternative referral channels for care over-
seas [15,18], may  have contributed to this minimal impact.
The lack of active information dissemination and the con-
trolling manner in which the directive was implemented
were also perceived as being of critical importance in pre-
venting the much-feared patient exodus.
Whilst the implementation of systems and mechanisms
to facilitate cross-border care as set out in the direc-
tive demonstrate the phenomenon of “downloading” [10]
where the MS  has to comply with the EU, this study has also
illustrated how implementation of the directive could be
having a broader effect on domestic health services policy
in terms of compliance, opportunism and usage of Europe
[5,35,36]. Policy makers appear to have acted as norm
entrepreneurs in the case of the legislation on patients’
rights, clariﬁcation of entitlement and indemnity insurance
with the directive giving them added strength to argue
for implementation. The study provides an example of the
‘bounded rationality’ theory [35,37] where policy makers
may  have not taken a holistic approach to the directive
and chose to concentrate on instrumentalising the direc-
tive to bring about long-overdue structural reforms in the
domestic health system whilst taking steps to mitigate
against the anticipated negative ﬁnancial and public health
impact [37]. Similar developments could be observed in
other small countries. In Latvia and Luxembourg [38,39] for
example, the directive also reportedly provided an oppor-
tunity to set up a legal framework for patients’ rights
and appears to have provided the opportunity for obliga-
tory professional indemnity insurance to be introduced for
health care professionals other than doctors speciﬁcally in
Luxembourg [39].
The study has certain limitations. Whereas a careful
selection took place to ensure a broad range of participants
among decision-makers in health, patient representatives
were not included. The results derived from the study are
closely associated with the Maltese health care system’s
unique features including the geo-demographic conditions
and long tradition of organised cross-border referrals for
highly specialised care. It is therefore acknowledged that
the ﬁndings may  not be easily generalisable to other con-
texts.
Nonetheless, the dynamics discussed here are ones
that could be reasonably expected to be visible in other
countries. Hence, comparative analysis of stakeholder
perspectives using a Europeanisation perspective from dif-
ferent Member States should be carried out to obtain a
picture of the real impact of the directive on the various
health systems. Such studies could be important to further
elucidate prevailing gaps in service provision and inequal-
ities between the different regions in Europe which the
current directive has so far failed to address. Observations
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btained from the grassroots key actors within domes-
ic health systems could lead to useful research that may
nform future steps for a genuine European cross-border
ealth policy. This would be grounded in public health
eeds assessment as opposed to political ideology and legal
mperatives. Close monitoring of the unfolding impact of
he directive across the EU is warranted.
onclusion
This study has provided an insight into the implemen-
ation of the patients’ rights and cross border directive
nd its early outcomes, as observed through the lens of
 small EU Member State with a long-standing tradition
f organised cross-border health collaboration. It has illus-
rated how Europeanisation of health systems through this
eminal legislation on health services has occurred through
oth passive downloading and active utilisation of the EU
ules. The indication is that the impact of the Directive in
erms of additional patient mobility will be minimal and
he Directive is more important in terms of the domestic
ealth system changes it has triggered.
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